Inventor · disambiguated record
Kenneth Valenzano
Also filed as: VALENZANO KENNETH · VALENZANO KENNETH JOSEPH
13 granted patents·5 pending applications·188 citations·filing 2009–2023
91Inventor score
Top patents by PatentIndex Score
18 records- 0196US10357548B2α-galactosidase A and 1-deoxygalactonojirimycin co-formulationAMICUS THERAPEUTICS INC·Filed 2017·Granted Jul 23, 2019·49 cites·18 claims
- 0296US10155027B2Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry diseaseAMICUS THERAPEUTICS INC·Filed 2017·Granted Dec 18, 2018·49 cites·19 claims
- 0395US9694056B2α-galactosidase A and 1-deoxygalactonojirimycin co-formulationAMICUS THERAPEUTICS INC·Filed 2013·Granted Jul 4, 2017·50 cites·16 claims
- 0492US9404100B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Granted Aug 2, 2016·16 cites·20 claims
- 0592US9303249B2High concentration α-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·15 cites·18 claims
- 0687US10512677B2High concentration alpha-glucosidase compositions for the treatment of pompe diseaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·4 cites·15 claims
- 0787US10046033B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2016·Granted Aug 14, 2018·4 cites·20 claims
- 0881US12419937B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·18 claims
- 0979US2024115708A1Dosing Regimens For The Treatment Of Fabry DiseaseAMICUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1072US9381194B2Pharmacological chaperones for treating obesityFAN JIAN-QIANG·Filed 2009·Granted Jul 5, 2016·1 cites·16 claims
- 1171US11278599B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2019·Granted Mar 22, 2022·0 cites·20 claims
- 1265US2020268890A1Dosing Regimens For The Treatment Of Fabry DiseaseAMICUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1356US2018153999A1Dosing Regimens For The Treatment Of Fabry DiseaseAMICUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1453US9937165B2Pharmacological chaperones for treating obesityAMICUS THERAPEUTICS INC·Filed 2016·Granted Apr 10, 2018·0 cites·16 claims
- 1553US2014219986A1Dosing regimens for the treatment of fabry diseaseGREENE DOUGLAS STUART·Filed 2012·Application pending·0 cites
- 1649US9931353B2Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidasesAMICUS THERAPEUTICS INC·Filed 2015·Granted Apr 3, 2018·0 cites·6 claims
- 1746US9044437B2Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidasesWUSTMAN BRANDON·Filed 2010·Granted Jun 2, 2015·0 cites·12 claims
- 1840US2015086530A1Dosing regimens for the treatment of pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth Valenzano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →